Alan Tenenbaum concentrates his practice on commercial and intellectual property litigation and counseling. He represents corporate clients throughout the United States and before the International Trade Commission in litigation involving patent, trademark, unfair competition, right of publicity, and commercial claims. His litigation and trial work includes matters involving electronic hardware, software, consumer products, medical devices, chemicals, and both branded and generic pharmaceuticals.
Alan is a trusted general counsel to a variety of companies. Applying business solutions from a legal perspective, he works with clients to identify, acquire, protect, manage, and monetize products, technology, and intellectual property rights.
Alan counsels clients who seek to resolve and avoid commercial and intellectual property disputes, with and without recourse to litigation and has litigated and resolved a variety of disputes involving nuisance patents and patent assertion entities. He also negotiates IP and IT agreements and other complex agreements involving technology. Alan has a successful track record in the prosecution of patent applications involving software-implemented applications.
Alan frequently speaks and writes on the topic of patent litigation, software patents, and intellectual property involving emerging technology. He has been named in New York Super Lawyers® for several years, most recently in 2021. He is also rated AV by Martindale-Hubbell.
Alan Tenenbaum was selected to the 2021 Super Lawyers list. The Super Lawyers List is issued by Thompson Reuters. A description of the selection methodology can be found here.